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1. Introduction
  Multi-genes involvement and abnormality of multi-signal 
transduction pathway are found to play an important role in the 
genesis, development, invasion and metastasis of gastric carcinoma, 
which provides a theoretical basis for treating gastric cancer with 
gene therapy[1-5]. The expression of vascular endothelial growth 
factor receptor (VEGFR), to a certain extent, is controlled by the 
expression of cyclophilinB (CypB). VEGFR expression in gastric 
cancer has a close relationship with lymph node metastasis in 
patients suffered from gastric cancer, and its high expression in 
gastric cancer cells often indicates poor prognosis of patients[6]. 
Hence, down regulating the expression level of CypB and thereby 
inhibiting the activity of VEGFR could be an important means 
to treat gastric cancer. CypB also plays an important role in 
endonuclear transcription activation[7-10]. Dieriks et al found that 
within the fibrillar centers CypB interacts with RNA polymerase, 
dyskerin (DCK1) and fibrillarin and is involved in ribosome 
biogenesis and RNA transcription[11]. In addition, CypB is 
involved in various cancer-promoting signaling pathways in liver 
cancer, pancreatic cancer, breast cancer and other tumors[12-14], 
significantly influencing the malignant development of tumors. 
Objective: To determine the effect of gene silencing of cyclophilin B (CypB) on growth and 
proliferation of gastric cancer cells. Methods: CypB siRNA lentivirus (LV-CypB-si) and 
control lentivirus (LV-si-con) were produced. CypB expression in gastric cancer cell lines was 
detected by Western blot. BGC823 and SGC7901 cells were chosen to be infected with LV-si-
con and LV-CypB-si, and stable transfectants were isolated. The cell groups transfected with 
LV-CypB–siRNA, LV-siRNA-con and transfected no carrier were served as the experimental 
group, the implicit control group and the blank control group respectively. MTT and colony 
formation assays were used to examine the effect of CypB on the cell growth and proliferation 
in vitro. Cell cycle was analyzed with flow cytometry. The expression of VEGFR of BGC823-
si and SGC7901-si was detected by Western blot. Results: Gene silencing of CypB can 
inhibit gastric cancer cell growth, proliferation, cell cycle progress and tumorigenesis. CypB 
expression level was obviously higher in SGC7901 and BGC823 than MKN28 and GES. 
These two cell lines were infected with LV-si-con and LV-CypB-si respectively. MTT and 
cloney formation assays showed a significantly decreased rate of cell proliferation from the 
forth day or the fifth day in cells transfected with LV-CypB-si (P<0.05). Down-regulation 
of CypB resulted in slightly decreased percentage of S phase and increased percentage of G1 
(P<0.05). These findings indicated that CypB could promote the G1-S transition of gastric 
cancer cell. In addition, the expression of VEGF of BGC823 and SGC7901 transfected with 
CypB siRNA was reduced in comparison with the implicit control group and the blank control 
group. Conclusions: Gene silencing of CypB decreases gastric cancer cells proliferation and 
in vivo tumorigenesis. These findings indiccate CypB could be a potential biomarker and 
therapeutic target for gastric cancer.
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In tumors like breast tumor, proliferation and migration of tumor 
cells can be remarkably inhibited through CypB gene silencing, 
which undoubtedly point out a new direction for the treatment of 
gastric cancer[15].  However, at present the specific role of CypB 
in gastric cancer remains unclear, and the reports on using CypB 
down regulation as gene therapy for cancer are scarce. Hence, to 
determine the effect of gene silencing of CypB on the growth and 
proliferation of gastric cancer cells CypB siRNA lentivirus (LV-
CypB-siRNA) and corresponding control lentivirus (LV-siRNA-
con) were produced and transfected into BGC823 and SGC7901 cell 
lines. And then detection and comparison of the growth, proliferation 
and monoclonal forming capacity of these cells were carried out 
to confirm our hypothesis that gene silencing of CypB may have 
impact on the growth and proliferation of gastric cancer cells. At the 
same time, the expression of VEGFR in CypB-silenced BGC823 
and SGC7901 cell lines was also explored so as to provide a basis 
for further research on mechanism of the effect of CypB on gastric 
cancer. 
2. Materials and methods
2.1. Reagents and instruments
  GES, SGCSGC7901, MKN-28 and BGC823 cell lines were all 
procured from Institute of Biochemistry and Cell Biology, SIBS, 
CAS. DMEM and 1604 cell culture medium were purchased from 
HYCLONE Ltd., USA. Fetal calf serum was from GIBCO Ltd., 
USA. ECL Western Blot kits were purchased from Santa Cruz Ltd., 
USA. PCR primer (R&F) was produced by Shanghai Genechem 
Ltd., China and TEMED was obtained from Beijing Beyotime Ltd., 
China.
2.2. Construction of LV-CypB-siRNA
  In the present study, interference or random sequences of siRNA 
were inserted in the corresponding restriction enzyme cutting site 
of lentivirus vector GV115 and the sequence of the components 
were as follow: hU6-MCS-CMV-EGFP. The vector contains 
green fluorescent protein sequences and EGFP can be used as an 
indicator of transfection efficiency. The sequence of CypB siRNA 
was GGTGGAGAGCACCAAGACA and the vector was GV115. 
Single-stranded DNA oligo containing interference sequence was 
chemically synthesized, then annealing to produce double strands. 
The synthesized DNA was connected to the digested lentiviral vector 
RNAi at the restriction enzyme cutting sites, Age栺 and EcoR栺. 
and the synthesized product was transfected into the prepared cells. 
When positive clone of LV-CypB-siRNA was confirmed by PCR, 
the sequences was detected and the results were compared. 
2.3. Cell culture
  Gastric cancer cell lines SGC7901 and BGC823 were cultured 
in a medium containing 10% fetal bovine serum, vaccinated in 10 
cm cell culture dishes, and kept in incubator under 37 曟 and 5% 
CO2. SGC7901 and BGC823 cells were inoculated onto 24-well 
cell culture plates with 4暳10
4 cells per well. The virus were taken 
out of the refrigerator, centrifuged and diluted 10 times on the ice. 
A volume of 10 μL lentiviral vector dilution was added to the cell 
culture at a MOI of 10. The culture solution was renewed after 
the overnight incubation. After 72 h fluorescence was observed 
under inverted fluorescence microscope to estimate the infection 
efficiency of the lentiviral vector into cells. When the cells full filled 
the well, they were gradually subcultured into 6-well plates and 
25 cm culture flasks. The cell groups transfected with LV-CypB-
siRNA, LV-siRNA-con and transfected no carrier were served as the 
experimental groups (BGC823-si group and SGC7901-si group), 
the implicit control groups (BGC823-con group and SGC7901-con 
group) and the blank control groups (BGC823 group and SGC7901-
con group) respectively, frozen for further use. 
2.4. Western blot detection of the CypB expression in gastric 
cancer cell lines
  After transfection about 5暳10
6 of gastric cancer cells in logarithmic 
phase were collected, washed twice with cold PBS. Cell lysis buffer 
(100 μL) was added into the collected cells, kept in ice-bath for 30 
min and centrifuged at 12 000 g/min at 4 曟 for 10 min. The total 
proteins were extracted by BCA protein assay kit and then separated 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The gels were transferred onto nitrocellulose membranes 
under 80 V constant voltage. Membranes were blocked using 
10 mL 10% defatted milk and corresponding primary antibody 
CypB (Abcam 1:1 000) were added. After incubated overnight 
at 4 曟 membranes were washed with TBST. Defatted milk (2%) 
was used to dilute the corresponding HRP-conjugated secondary 
antibody (1:2 000), and the membranes were incubated at room 
temperature for 1-2 h, and developed using ECL after washing with 
TBST. Bandscan 5.0 software was employed to detect the grey 
level of the bands. The ratio of grey levels of the targeted band and 
the corresponding 毬-actin was regarded as the indicator of the 
expression level of the targeted protein samples.
2.5. Determination of cell proliferation by MTT test
  BGC823-si, BGC823-con, BGC823, SGC7901-si, SGC7901-con 
and SGC7901 cells were inoculated. Single-cell suspension was 
prepared using 1640 cell culture medium containing 10% fetal calf 
serum. Then the suspension was inoculated onto 96-well plates with 
1 000 cells per well and the volume was 200 μL per well. After 3 
days culture in the incubator at 37 ℃ and 5% CO2, 20 μL of MTT 
solution (5 mg/mL) was added to each well. After 4 h incubation 
at 37 ℃, the culture of cells was terminated. The supernatant in the 
wells was removed. The 150 μL DMSO was added into each well, 
shaking for 10 min to sufficiently dissolve the crystal substance. 
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Then enzyme-linked immunosorbent assay was used to detect the 
absorbance at 490 nm for each well. Cell growth curves in each 
groups were plotted with time as x-axis and the mean absorbance in 
three wells as y-axis. 
2.6. Colony formation assays 
  Cells in logarithmic phase in each group (SGC7901-si group, 
SGC7901-con group, BGC-si group and BGC-con group) were 
selected, digested by 25% trypsin, separated into single cell and 
suspended in 1640 culture medium containing 10% fetal calf 
serum for further use. Gradient dilution of the cell suspensions was 
performed. Cells in each group were gradiently inoculated into 37 ℃ 
preheated culture medium (10 mL) with 500 cells per dish, gently 
shaking to make the cells homogeneous spread. Then cells were 
cultured in incubator under 37 ℃, 5% CO2 and saturated humidity 
for 2-3 weeks. Culture medium was changed every two days until 
the formation of typical clone of the cells. The supernatants were 
removed and the cells were washed with PBS buffer twice. Cells 
were fixed with 4% paraformaldehyde (4%) for 15 min. After 
removing of the fixing liquid and 30-min GIMSA staining, cells 
were washed slowly with running water, dried in air and counted 
with naked eye.
2.7. Cell cycle assay
  Cells in each group (experimental, implicit control and blank 
control groups) were inoculated onto 60 mm culture plates (1暳
106 for each group of cells). After 48 h cells were collected by 
tyrisin digestion, washed by PBS buffer and the supernatants were 
removed. Precooled ethyl alcohol (1 mL, 70%) was added; cells 
were homogenized and kept in refrigerator for fixing for more than 
12 h. Then cells were washed with PBS to remove ethyl alcohol, 
centrifuged twice at 100 rpm for 5 min. Cells were resuspended with 
0.5 mL PBS. PI and RNaseA were added and adjusted to the final 
concentration of 50 g/mL, kept in warm bath at 37 ℃ for 30 min. 
Cell cycle was determined using flow cytometry.
2.8. VEGFR expression in gastric cancer cells by Western blot 
assay
  After adding RIPA lysis buffer the collected cells were placed 
on the ice for 30 min, centrifuged at 12 000 rpm under 4 ℃ for 5 
min, and the supernatants were collected. The total proteins were 
extracted by BCA protein assay kit and then separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
The gels were transferred onto nitrocellulose membranes under 80 
V constant voltage. Membranes were blocked using 10 mL 10% 
defatted milk and corresponding primary antibody were added. After 
incubated overnight at 4 ℃ membranes were washed with TBST. 
The corresponding HRP-conjugated secondary antibody (1:5 000) 
were added into the membranes, incubated for 1 h, and developed 
using ECL after washing with TBST. Bandscan 5.0 software was 
employed to detect the grey level of the bands. The ratio of grey 
levels of the targeted band and the corresponding 毬-actin was 
regarded as the indicator of the expression level of the targeted 
protein samples.
2.9. Statistical analysis
  All the experiments were repeated for at least three times. Graph-
Pad Prism 4 (GraphPad Software, La Jolla, CA) was employed for 
statistical analysis. Results in each group were analyzed by Student’s 
t test and  P<0.05 was regarded as significantly difference.
3. Results
3.1. Construction of LV-CypB-siRNA
  The sequencing assay showed that the target sequence has been 
successfully inserted, suggesting that the pGV115-CypB-siRNA 
plasmid was successfully constructed (Figure 1). 
CTAGAGAGATAaTTGGaATTAATTTGACTGTAAACACAAAGATATTA
GTACAAAA
TACGTGACGTAGAAAGTAATAATTTCTTGGGTAGTTTGCAGTTTTAA
AATTATGT
TTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTCGA
TTTCTTGGC
TTTATATATCTTGTGGACAGGACGAAACACCGGAAGGTGGAGAGCA
CCAAGAC
ACTCGAGTGTCTTGGTGCTCTCCACCTTTTTTTTGAATTTCGGGATC
CATTTAGG
GCGGGCCGGCGTGGAATAAACCGTATTACCGGCCATGCCATAAGTT
TATTAAAT
AAGTAATTCAATTTACGGGGCTCTTTAGTTTCATAAGCCCATATATT
GGAGTTTC
GGCGTTTACATACCTTACGGAAATGGCCCGCCTGGTTGACCGCCCA
ACGACCCC
GGTCTATTGACGTCATAATGACGTATGTTCCCATAGTAACGCGATAG
GGACTTTC
CACTGACGTACTGGGTGGAGGAC
 (Sequence marked with red is designed siRNA sequence).
Figure 1. Sequencing results of lentivirus vector after inserted with isRNA.
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3.2. CypB expression in gastric cancer cell lines
  Western blot was used to detect the expression of CypB in 
immortalized gastric epithelial cells line GES, gastric cancer cell line 
MKN28, SGC7901 and BGC823. It was found that the expression 
of CypB was lower in GES and MKN28 but higher in SGC7901 
and BGC823 cell lines (Figure 2). Therefore we chose SGC7901 
and BGC823 cells to infect with lentivirus CypB-siRNA CypB for 
further functional study on CypB.
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Figure 2. Expression of CypB in gastric cancer cell line BGC823, SGC7901, 
MKN28 and immortalized gastric epithelial cells line GES.
Compared with expression of 毬-action (43 kd), the expression of CypB (21 
kd) was lower in GES and MKN28 and higher in SGC7901 and BGC-823 
cells.
3.3. Determination of cell proliferation by MTT assay
  According to the results of MTT assay, it was found that the growth 
rate of LV-CypB-siRNA infected BGC823 and SGC7901 cells, 
compared with the blank control group and implicit control group, 
started to significantly slow down from the fourth and fifth days, 
respectively (P < 0.05) (Figure 3A and 3B), while there was no 
statistically significant differences between the blank control group 
and implicit control group.
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Figure 3. Determination of cell proliferation by MTT assay.
A: Cell growth (OD value) in BGC823-si group was significantly slow down 
from the fourth day compared with BGC823 group and BGC823-con group 
(P<0.05); B: Cell growth (OD value) in SGC7901-si group was significantly 
slow down from the fifth day compared with SGC7901 group and SGC7901-
con group (P<0.05).
3.4. Determination of clonality using colony formation assay
  The clonality of the single cell in experimental group, negative 
control and blank control groups were ca were detected using colony 
formation assay. After infected with LV-CypB-siRNA the clonality 
of the BGC823 and SGC7901 cells were reduced compared with 
that in control groups (P<0.05) (Figure 4).
3.5. Determination of cell growth and proliferation capacity 
by cell cycle assay
  After transfection of CypB siRNA in BGC823 and SGC7901 the 
proportion of cells in G1 phase increased while cells in S phase 
significantly decreased compared with that in negative control group 
and blank control group (P<0.05) (Figure 5A and 5 B). 
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Figure 4. Effect of CypB on the clone formation capacity of BGC823 and 
SGC7901 gastric carcinoma cells.
A: The clone formation capacity of LV-CypB-siRNA infected BGC823 cells 
were significantly reduced compared with BGC823 (t=15, P=0.04) and 
BGC823-con group (t=21, P=0.03); B: The clone formation capacity of LV-
CypB-siRNA infected SGC7901 cells were significantly reduced compared 
with SGC7901 (t=25, P=0.01) and SGC7901-con group (t=22, P=0.03).
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Figure 5. Effect of CypB gene silencing on the cell cycles of BGC823 and 
SGC7901 cells.
A: Compared with BGC823-con and BGC823 groups, cells in G1 phase 
increased and cells in S phase significantly decreased in BGC823-si group 
(P<0.05); B: Compared with SGC7901-con and SGC7901 groups, cells in G1 
phase increased and cells in S phase significantly decreased in SGC7901-si 
group (P<0.05).
3.6. VEGFR expression in gastric cancer cells by Western blot 
assay
  CypB and CD147 are mutually ligand and receptor. And it is 
known that CD147 is closely related to tumor. It can regulate matrix 
metalloproteinases (MMP2, MMP9, and VEGFR) and involves in 
regulating the growth, proliferation and metastasis of tumors. We 
detected the expression of VEGFR in CypB silenced BGC823 and 
SGC7901 gastric cancer cells (Figure 6). And the results showed 
that compared with negative control group and blank control group, 
the expression of VEGFR in CypB siRNA transfected BGC823 and 
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SGC7901cells were reduced, especially in CypB siRNA transfected 
BGC823 cells (BGC823-si group).
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Figure 6. Western blot detection of VEGFR expression in CypB gene silenced 
BGC823 and SGC7901 cells .
The expression of VEGFR in BGC823-si group was significantly decreased 
compared with BGC823-con and BGC823 groups. The expression of VEGFR 
inSGC7901-si group was slightly decreased compared with SGC7901-con 
and SGC7901 groups. And the expression of 毬-action in each group did not 
show much difference.
4. Discussion
  Many studies have shown that Cyp is a kind of multifunctional 
protein which is likely to play an important role in diseases such 
as tumor[16-18]. For example, CypA, highly homologous with 
CypB, shows significantly increasing amount of expression in 
hepatocellular carcinoma, lung cancer, pancreatic cancer and 
endometrial cancer expression[19-22]. The high expression of the 
members of Cyp proteins in malignancy tissue is likely to be closely 
correlated with the genesis and development of the malignant tumor. 
However, relevant research on the effects of CypB expression 
level on the cancer cells is rare, and its specific role and possible 
mechanism of action remains unclear. By silencing the expression 
of CypB, the present study detected its effect on the growth, 
proliferation and monoclonal formation ability, and also verified that 
CypB gene silencing can be used as a new method of gastric cancer 
treatment. At the same time its possible mechanism of action was 
explored.
4.1. CypB may be closely associated with the growth and 
migration of gastric cancer cells
  In the present study LV-CypB-siRNA and the corresponding control 
carrier (LV-siRNA-con) were used to transfect gastric cancer cell 
lines BGC823 and SGC7901. Results showed after LV-CypB-siRNA 
was stablely transfected into BGC823 and SGC7901, the growth and 
proliferation ability, monoclonal formation ability and in vivo tumor 
formation ability were significantly diminished compared with 
control group. The cell cycle in G1/S phase was blocked, suggesting 
CypB gene silencing can effectively inhibit the growth, invasion and 
migration of gastric cancer cells. At the same time, CypB siRNA 
inhibited the development of the cell cycle, blocking the cell phase 
in G1 and S phases. Meza-Zepedu et al found that CypD and FK506 
binding protein4 (FKBP4), CypAL-4A and NIMA - interacting 
protein l (Pinl) were highly expressed in breast cancer, osteosarcoma 
and squamous cell carcinoma of the head and neck, respectively[23-
25]. In addition, Leong et al reported that by down regulating the 
expression of CypB in breast cancer cells, cell growth, proliferation 
and migration were inhibited[26]. By studying the expression profile 
of CypB gene silenced breast cancer cells and control cells, it was 
found that expression of 663 genes were changed, among which 
expression of 297 genes were up regulated and 366 genes were down 
regulated including stathminlike 3 (STMN3) which is closely related 
to the invasion of tumors. In addition, expression of S100A4 whose 
relation with breast cancer has been studied in many researches was 
also significantly decreased, and it plays an important role in tumor 
invasion and metastasis[14,27]. The results of the effect of CypB in 
breast cancer indirectly support our experimental conclusion, namely 
CypB plays an important role in gastric cancer, and may be closely 
related with tumor growth and migration.
4.2. CypB gene silencing can effectively decrease the 
expression of VEGFR in gastric cancer cells
  To study the progress mechanism of CypB involved in gastric 
cancer, the proteins of CypB siRNA infected BGC823 cells and 
control cells were collected, and the VEGFR expression was 
detected by using western blot method. It was found that after 
decrease the expression of CypB, the expression of VEGFR 
was also significantly decreased compared with that of control 
group. Kim et al found that when oxygen is deficient, hypoxia-
inducible factor HIF-1 can directly act on CypB promoter, leading 
to its increasing expression[28]. They also found that CypB works 
together with STAT3 in the promoter region of HIF-1, producing 
a feedback regulation of HIF-1 expression. CypB can protect 
tumor cells (including p53-absent cells) from apoptosis induced 
by anti-hypoxic and cis-platinum. In addition, under the hypoxic 
condition, overexpressed CypB can induce more release of VEGFR 
and generation of new vessels[29,30]. The present study verified 
that decreasing the expression of CypB in gastric cancer will 
simultaneously decrease the expression of VEGFR, suggesting 
that CypB may be involved in regulating the signaling pathway of 
VEGFR. The results show that CypB may be involved in promoting 
development of gastric cancer, and CypB could be a potential 
therapeutic target in gastric cancer treatment. However, its specific 
mechanism remains to be further studied and discussed.
4.3. Deficiency of the present study
  Our work is imperfect. We have just performed an in vitro study 
of CypB gene silencing in gastric cancer, and further in vivo study 
is needed to verify its effects. In addition, the mechanisms of CypB 
involved in development of gastric cancer was not deeply studied, 
which is a deficiency of the present study. Hence further research is 
needed.
  In conclusion, CypB may be related with the growth, invasion and 
migration of gastric cancer cells. CypB gene silence may influence 
the growth and proliferation of the gastric cancer cells, providing a 
new prospect for the gene therapy of gastric cancer. Furthermore, 
CypB gene silience also decreases the expression of VEGFR, which 
provides a basis for further study on the mechanism of CypB in 
gastric cancer.
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